IP Library Patent Application 18417034
Patent Application
App. No. 18/417,034

Process For Purifying Sialylated Oligosaccharides

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/417,034
Abstract

Disclosed is a method for purifying sialylated oligosaccharides from a fermentation broth, cell-lysate or biocatalytic reaction mixture for obtaining high amounts of desired sialylated oligosaccharides in high purity. The method is particular suitable for the large-scale economic purification of sialylated human milk oligosaccharides (such as 3′-sialyllactose, 6′-sialyllactose or sialylated lacto-N-tetraose derivatives) from microbial fermentation, using recombinant bacterial cells or yeast cells. The obtained material is of high purity and can be used for food or medical application such like medical nutrition products, infant formula, dietary supplements, general nutrition products (e.g. dairy drinks).

Claims (10)

1 .- 23 . (canceled)

24 . A nutritional composition comprising at least one sialylated oligosaccharide, wherein said at least one sialylated oligosaccharide has been produced by microbial fermentation, and wherein said nutritional composition is a medicinal formulation, a dietary supplement, a dairy drink, or an infant formula.

25 . The nutritional composition of claim 24 , wherein the at least one sialylated oligosaccharide is at least one sialylated human milk oligosaccharide (HMO).

26 . The nutritional composition of claim 25 , wherein the at least one sialylated HMO is selected from 3′-SL, 6′-SL, LST-a, LST-b, LST-c, F-SL, DS-LNT, and F-LSTb.

27 . The nutritional composition of claim 25 , wherein the nutritional composition comprises at least 5 HMOs, and wherein the at least 5 HMOs are selected from 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, 3′-sialyllactose, and 6′-sialyllactose.

28 . The nutritional composition of claim 24 , wherein the nutritional composition comprises at least one sialylated HMO, at least one neutral HMO, and a probiotic microorganism.

29 . The nutritional composition of claim 24 , wherein the nutritional composition comprises: a) at least one sialylated HMO; and b) galactooligosaccharides (GOS) and/or fructooligosaccharides (FOS).

30 . A spray-dried, GMO-free powder consisting essentially of a sialylated oligosaccharide with a purity of >80% by dry-weight and possessing less than 10% water by weight, wherein the sialylated oligosaccharide has been produced by microbial fermentation, and wherein the spray-dried powder is capable of being formulated into a nutritional composition selected from a medicinal formulation, a dietary supplement, a dairy drink, and an infant formula.

31 . The spray-dried powder of claim 30 , wherein the sialylated oligosaccharide is selected from 3′-sialyllactose, 6′-sialyllactose, and a mixture of 3′-sialyllactose and 6′-sialyllactose.

32 . The spray-dried powder of claim 31 , wherein the spray-dried powder consists essentially of a mixture of 3′-sialyllactose, 6′-sialyllactose, and one or more neutral HMOs, wherein the one or more neutral HMOs are selected from 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, and lacto-N-fucopentaose I.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Sep 11, 2024
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 068944/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2024
From: JENNEWEIN, STEFAN; HELFRICH, MARKUS; ENGELS, BENEDIKT
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 067007/0914 →